Abstract
Introduction
Pyoderma gangrenosum (PG) can represent a diagnostic challenge, leading to missed or delayed diagnosis. With prolonged immunosuppressive therapy, the risk of infections is elevated, predisposing patients to receive anti-infective treatments and, in serious cases, amputations. Limb amputations have been reported as complication of PG misdiagnosis but can also occur as a complication of long-standing PG ulcers.
Methods
We aimed to describe the clinical characteristics of patients with PG leading to limb amputation through a multicenter retrospective case series between 2010 and 2020 including patients with PG who underwent limb amputation. We report a descriptive analysis of these patients’ clinical course and outcome.
Results
Ten patients with PG who underwent at least one limb amputation were identified. Six were male (60%). Mean age was 65 years. All patients had ulcerative PG on the lower extremities, with a mean PG ulcer duration of 30.6 months. Six patients had PG-related comorbidities such as ulcerative colitis, myelodysplasia, and inflammatory arthritis. Other significant comorbidities included diabetes mellitus (DM) (five patients), coronary artery disease (five patients), and chronic kidney disease (two patients). The majority of patients (8/10) were correctly diagnosed with PG prior to amputation, whereas two patients were misdiagnosed with necrotizing soft tissue infections (NSTIs). All patients received intravenous antibiotics without substantial improvement. Eight patients developed sepsis and shock-like symptoms and the diagnosis of NSTIs was considered. Below-knee amputation was performed in six patients and above-knee amputation in four. Four patients had amputation performed twice because of recurrent NSTIs.
Conclusion This multicenter case series sheds light on practice gaps for physician assessing patients with PG, in that limb amputation may result from PG misdiagnosis or complications thereof. Elderly patients (above 65 years) with coexisting lower extremity PG, DM, and/or chronic cardiac or renal disease should be managed with particular care toward preventing infection/NSTIs to prevent further complications such as limb amputations.
Data availability
All data generated or analysed during this study are included in this published article and its supplementary information files.
References
Barańska-Rybak W, Kakol M, Naesstrom M, Komorowska O, Sokołowska-Wojdyło M, Roszkiewicz J (2011) A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply. Am Surg 77(12):1644–1649
Ben Abdallah H, Bech R, Fogh K, Olesen AB, Vestergaard C (2021) Comorbidities, mortality and survival in patients with pyoderma gangrenosum: a Danish nationwide registry-nested case-control study. Br J Dermatol. https://doi.org/10.1111/bjd.20474
Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP (2000) Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 79(1):37–46
Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250
Cirotteau P, Heron-Mermin D, Dimicoli-Salazar S, Gérard E, Leroy H, Clément L, Beylot-Barry M (2019) Pyoderma gangrenosum misdiagnosed as necrotising fasciitis or a real association between the two? J Eur Acad Dermatol Venereol 33(8):e305–e306
Gavioli EM, Casias M, Ngo L (2020) Pyoderma gangrenosum and superimposed infection: a case report. Adv Skin Wound Care 33(6):1–3
Haag C, Hansen T, Hajar T, Latour E, Keller J, Shinkai K, Ortega-Loayza AG (2021) Comparison of three diagnostic frameworks for pyoderma gangrenosum. J Invest Dermatol 141(1):59–63
Haag CK, Nutan F, Cyrus JW, Satpathy J, Shinkai K, Ortega Loayza AG (2019) Pyoderma gangrenosum misdiagnosis resulting in amputation: a review. J Trauma Acute Care Surg 86(2):307–313
Jemec GB, Konradsen L (1994) Pyoderma gangrenosum complicated by necrotizing fasciitis. Cutis 53(3):139–141
Jockenhöfer F, Klode J, Kröger K, Roesch A, Al Ghazal P, Dissemond J (2016) Patients with pyoderma gangrenosum: analyses of the German DRG data from 2012. Int Wound J 13(5):951–956
Nawijn F, Smeeing DPJ, Houwert RM, Leenen LPH, Hietbrink F (2020) Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg 15:4
Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, Ortega-Loayza AG, Cohen J, McCalmont TH, Demer AM et al (2019) Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol 155(1):79–84
Shaigany S, Wong PW, Caplan A, Kim RH, Femia A (2021) Diagnostic work-up and treatment in patients with pyoderma gangrenosum: retrospective analysis of US insurance claims-based data. Arch Dermatol Res. https://doi.org/10.1007/s00403-021-02278-z
Weenig RH, Davis MD, Dahl PR, Su WP (2002) Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 347(18):1412–1418
Xia FD, Liu K, Lockwood S, Butler D, Tsiaras WG, Joyce C, Mostaghimi A (2018) Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum-A retrospective analysis. J Am Acad Dermatol 78(2):310-314.e311
Funding
There is no funding source.
Author information
Authors and Affiliations
Contributions
A.O. designed the study. H.S., B.W., S.I. and E.X. collected the data. H.S. and A.O. wrote the main manuscript. J.L., M.S. and A.M. reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shakshouk, H., Lehman, J.S., Wu, B. et al. Limb amputation in patients with pyoderma gangrenosum: a multi-institutional case series. Arch Dermatol Res 315, 1443–1448 (2023). https://doi.org/10.1007/s00403-022-02484-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-022-02484-3